Metagenomics and Community Profiling: Culture-Independent Techniques in the Clinical Laboratory

Clinical Microbiology Newsletter

Volumn 35, Issue 1, 2013, Pages 1-9

  Willner, Dana ^a   Hugenholtz, Phil ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER; RIBOSOME RNA; RNA 16S; SMALL SUBUNIT RIBOSOMAL RNA;

ANTIBIOTIC RESISTANCE; ARCHAEON; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL LABORATORY; CLOSTRIDIUM DIFFICILE; CYSTIC FIBROSIS; DNA EXTRACTION; DNA SEQUENCE; FUNGAL GENOME; HOST PATHOGEN INTERACTION; HUMAN; INCIDENCE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PYROSEQUENCING; RNA SEQUENCE; STATISTICAL ANALYSIS; SYSTEMIC MYCOSIS; TAXONOMY;

EID: 84871409631     PISSN: 01964399     EISSN: 18734391     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2012.12.001     Document Type: Article

References (88)

1. Staley J.T., Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Ann. Rev. Microbiol. 1985, 39:321-346.
2. Woese C.R. Bacterial evolution. Microbiol. Rev. 1987, 51:221-271.
3. Woese C.R., Fox G.E. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc. Natl. Acad. Sci. USA 1977, 74:5088-5090.
4. Barns S.M., et al. Remarkable archaeal diversity detected in a Yellowstone National Park hot spring environment. Proc. Natl. Acad. Sci. USA 1994, 91:1609-1613.
5. Reysenbach A.L., Wickham G.S., Pace N.R. Phylogenetic analysis of the hyperthermophilic pink filament community in Octopus Spring, Yellowstone National Park. Appl. Environ. Microbiol. 1994, 60:2113-2119.
6. Tringe S.G., Hugenholtz P. A renaissance for the pioneering 16S rRNA gene. Curr. Opin. Microbiol. 2008, 11:442-446.
7. Hugenholtz P., Tyson G.W. Microbiology: metagenomics. Nature 2008, 455:481-483.
8. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31:107-133.
9. Turnbaugh P.J., et al. The human microbiome project. Nature 2007, 449:804-810.
10. Dethlefsen L., McFall-Ngai M., Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449:811-818.
11. Carnt N., et al. Pathogenesis of contact lens-associated microbial keratitis. Optometry Vis. Sci. 2010, 87:612-613.
12. Rohwer F. Global phage diversity. Cell 2003, 113:141.
13. Mignard S., Flandrois J.P. 16S rRNA sequencing in routine bacterial identification: a 30-month experiment. J. Microbiol. Methods 2006, 67:574-581.
14. Sibley C.D., Peirano G., Church D.L. Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect. Genet. Evol. 2012, 12:505-521.
15. Hugenholtz P., Goebel B.M., Pace N.R. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J. Bacteriol. 1998, 180:4765-4774.
16. Engelbrektson A., et al. Experimental factors affecting PCR-based estimates of microbial species richness and evenness. ISME J. 2010, 4:642-647.
17. Nucleic acid techniques in bacterial systematics 1991, 115-175. John Wiley & Sons, New York. 1st ed. E. Stackebrandt, M. Goodfellow (Eds.).
18. Margulies M., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
19. Parameswaran P., et al. A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing. Nucleic Acids Res. 2007, 35:e130.
20. Caporaso J.G., et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 2011, 108(Suppl. 1):4516-4522.
21. Caporaso J.G., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336.
22. McDonald D., et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012, 6:610-618.
23. Magurran A.E. Measuring giological diversity 2003, 264. Wiley-Blackwell, West Sussex, United Kingdom. 1st ed.
24. Hamady M., Lozupone C., Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2009, 4:17-27.
25. Reshef D.N., et al. Detecting novel associations in large data sets. Science 2011, 334:1518-1524.
26. Wolfe A.J., et al. Evidence of uncultivated bacteria in the adult female bladder. J. Clin. Microbiol. 2012, 50:1376-1383.
27. Willner D., et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 2011, Accessed 17 December 2011. http://dx.doi.org/10.1038/ismej.2011.104.
28. Rudkjøbing V.B., et al. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis. J. Clin. Microbiol. 2011, abstract. Accessed 22 December 2011. http://jcm.asm.org/content/early/2011/10/14/JCM.06092-11.
29. Gill S.R., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
30. Dewhirst F.E., et al. The human oral microbiome. J. Bacteriol. 2010, 192:5002-5017.
31. Littman D.R., Pamer E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011, 10:311-323.
32. Sartor R.B. Intestinal microflora in human and experimental inflammatory bowel disease. Curr. Opin. Gastroenterol. 2001, 17:324-330.
33. McLaughlin S.D., et al. The bacterial pathogenesis and treatment of pouchitis. Thera. Adv. Gastroenterol. 2010, 3:335-348.
34. Marchesi J.R., et al. Towards the human colorectal cancer microbiome. PLoS ONE 2011, 6:e20447.
35. Benjamin J.L., et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm. Bowel Dis. 2011, Accessed 18 March 2012. http://www.ncbi.nlm.nih.gov/pubmed/22102318.
36. Giongo A., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011, 5:82-91.
37. Frank D.N., et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 2011, 17:179-184.
38. Hilty M., et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010, 5:e8578. 10.1371/journal.pone.0008578.
39. Yang L., et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009, 137:588-597.
40. Dinsdale E.A., et al. Functional metagenomic profiling of nine biomes. Nature 2008, 452:629-632.
41. Wagner P.L., Waldor M.K. Bacteriophage control of bacterial virulence. Infect. Immun. 2002, 70:3985-3993.
42. Foweraker J.E., et al. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J. Antimicrob. Chemother. 2005, 55:921-927.
43. Altschul S.F., et al. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
44. Benson D.A., et al. GenBank. Nucleic Acids Res. 2005, 33:D34-D38.
45. Angly F.E., et al. The GAAS metagenomic tool and its estimations of viral and microbial average genome size in four major biomes. PLoS Comput. Biol. 2009, 5:e1000593.
46. Moriya Y., et al. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 2007, 35:W182-W185.
47. Turnbaugh P.J., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
48. Turnbaugh P.J., et al. A core gut microbiome in obese and lean twins. Nature 2008, 457:480-484.
49. Belda-Ferre P., et al. The oral metagenome in health and disease. ISME J. 2011, 6:46-56.
50. Salminen S., et al. Interaction of probiotics and pathogens - benefits to human health?. Curr. Opin. Biotechnol. 2010, 21:157-167.
51. Snel J., et al. Competitive selection of lactic acid bacteria that persist in the human oral cavity. Appl. Environ. Microbiol. 2011, 77:8445-8450.
52. MacConnachie A.A., et al. Faecal transplant for recurrent Clostridium Difficile-associated diarrhoea: A UK case series. Q. J. Med. 2009, 102:781-784.
53. Khoruts A., et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44:354-360.
54. Wächtershäuser A., Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur. J. Nutr. 2000, 39:164-171.
55. Smillie C.S., et al. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 2011, 480:241-244.
56. Stecher B., et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc. Natl. Acad. Sci. USA 2012, 109:1269-1274.
57. Colomer-Lluch M., et al. Bacteriophages carrying antibiotic resistance genes in fecal waste from cattle, pigs, and poultry. Antimicrob. Agents Chemother. 2011, 55:4908-4911.
58. Fancello L., et al. Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota. J. Antimicrob. Chemother. 2011, 66:2448-2454.
59. Belda-Ferre P., et al. Mining virulence genes using metagenomics. PLoS ONE 2011, 6:e24975.
60. Thurber R.V., et al. Laboratory procedures to generate viral metagenomes. Nat. Protoc. 2009, 4:470-483.
61. Allander T., et al. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc. Natl. Acad. Sci. USA 2001, 98:11609-11614.
62. Chen E.C., et al. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. J Vis Exp 2011, Accessed 24 March 2012. http://www.ncbi.nlm.nih.gov/pubmed/21559002.
63. Willner D., Thurber R.V., Rohwer F. Metagenomic signatures of 86 microbial and viral metagenomes. Environ. Microbiol. 2009, 11:1752-1766.
64. Roux S., et al. Metavir: a Web server dedicated to virome analysis. Bioinformatics Accessed 7 May 2012. http://bioinformatics.oxfordjournals.org/content/early/2011/09/11/bioinformatics.btr519.
65. Angly F., et al. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information. BMC Bioinform. 2005, 6:41.
66. Reyes A., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010, 466:334-338.
67. Minot S., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011, 21:1616-1625.
68. Allander T., et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA 2005, 102:12891-12896.
69. Lysholm F., et al. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS ONE 2012, 7:e30875.
70. Heikkinen T., Järvinen A. The common cold. Lancet 2003, 361:51-59.
71. Finkbeiner SR, et al. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 2008, 4:e1000011.
72. Blinkova O., et al. Cardioviruses are genetically diverse and cause common enteric infections in South Asian children. J. Virol. 2009, 83:4631-4641.
73. Victoria J.G., et al. Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J. Virol. 2009, 83:4642-4651.
74. Palacios G., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med. 2008, 358:991-998.
75. Briese T., et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 2009, 5:e1000455.
76. Xu B., et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (ftls) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011, 7:e1002369.
77. McMullan L.K., et al. Using next generation sequencing to identify yellow fever virus in Uganda. Virology 2012, 422:1-5.
78. Yozwiak N.L., et al. Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl. Trop. Dis. 2012, 6:e1485.
79. Pfaller M.A., Diekema D.J. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 2010, 36:1-53.
80. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am. J. Med. 2012, 125:S14-S24.
81. Pashley C.H., et al. DNA analysis of outdoor air reveals a high degree of fungal diversity, temporal variability, and genera not seen by spore morphology. Fungal Biol. 2012, 116:214-224.
82. Borman A.M., et al. Evaluation of the viability of pathogenic filamentous fungi after prolonged storage in sterile water and review of recent published studies on storage methods. Mycopathologia 2006, 161:361-368.
83. Borman A.M., et al. Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J. Clin. Microbiol. 2009, 47:2307-2310.
84. Schoch C.L., et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc. Natl. Acad. Sci. USA 2012, 109:6241-6246.
85. Nilsson R.H., et al. Intraspecific ITS variability in the kingdom fungi as expressed in the international sequence databases and its implications for molecular species identification. Evol. Bioinform. Online 2008, 4:193-201.
86. Park H.K., et al. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS ONE 2012, 7:e32847.
87. Ghannoum M.A., et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010, 6:e1000713.
88. Delhaes L., et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS ONE 2012, 7:e36313.